The catalytic subunit of telomerase is expressed in developing brain neurons and serves a cell survival-promoting function

Journal of Molecular Neuroscience

Volumn 14, Issue 1-2, 2000, Pages 3-15

  Fu, Weiming ^a   Killen, Michael ^a   Culmsee, Carsten ^a   Dhar, Sonu ^b   Pandita, Tej K ^b   Mattson, Mark P ^a,c  

^a UNIVERSITY OF KENTUCKY   (United States)

^b The New York Presbyterian Hospital   (United States)

^c NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

Alzheimer's disease; Apoptosis; Caspase; Cerebral cortex; Hippocampus; Mitochondrial transmembrane potential; Neurotrophic factor; Parkinson's disease

Indexed keywords

TELOMERASE;

ANIMAL CELL; APOPTOSIS; ARTICLE; BRAIN DEVELOPMENT; CELL SURVIVAL; ENZYME ACTIVITY; ENZYME ANALYSIS; NERVE CELL DIFFERENTIATION; NONHUMAN; PROTEIN DETERMINATION; PROTEIN EXPRESSION; RODENT;

ANIMALIA; RODENTIA;

EID: 0034122088     PISSN: 08958696     EISSN: None     Source Type: Journal    
DOI: 10.1385/jmn:14:1-2:003     Document Type: Article

References (43)

1. Aloyz R. S., Bamji S. X., Pozniak C. D., Toma J. G., Atwal J., Kaplan D. R., and Miller F. D. (1998) p53 is essential for developmental neuron death as regulated by the TrkA and p75 neurotrophin receptors. J. Cell Biol. 143, 1691-1703.
2. Beal M. F. (1995) Aging, energy and oxidative stress in neurodegenerative disease. Ann. Neurol. 38, 357-366.
3. Blasco M. A., Funk W., Villeponteau B., and Greider C. W. (1995) Functional characterization and developmental regulation of mouse telomerase RNA. Science 269, 1267-1270.
4. Bodnar A. G., Ouellette M., Frolkis M., Holt S. E., Chiu C.-R, Morin G. B., et al. (1998) Extension of lifespan by introduction of telomerase into normal human cells. Science 279, 349-352.
5. Chan S. L. and Mattson M. P. (1999) Caspase and calpain substrates: roles in synaptic plasticity and cell death. J. Neurosci. Res. 58, 167-190.
6. Chan S. L., Tammariello S. P., Estus S., and Mattson M. P. (1999) Par-4 mediates trophic factor withdrawal-induced apoptosis of hippocampal neurons: actions prior to mitochondrial dysfunction and caspase activation. J. Neurochem. 73, 502-512.
7. Chin L., Artandi S. E., Shen Q., Tam A., Lee S. L., Gottlieb G. J., et al. (1999) p53 deficiency rescues the adverse effects of telomere loss and cooperates with telomere dysfunction to accelerate carcinogenesis. Cell 97, 527-538.
8. Cotman C. W. (1998) Apoptosis decision cascades and neuronal degeneration in Alzheimer's disease. Neurobiol. Aging. 19, S29-32.
9. Dirnagi U., Iadecola C., and Moskowitz M. A. (1999) Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci. 22, 391-397.
10. D'Mello S. R. (1998) Molecular regulation of neuronal apoptosis. Curr. Top. Dev. Biol. 39, 187-213.
11. Duan W., Zhang Z., Gash D. M., and Mattson M. P. (1999) Participation of Par-4 in degeneration of dopaminergic neurons in models of Parkinson's disease. Ann. Neurol. 46, 587-597.
12. Feng J., Funk W. D., Wang S.-S., Weinrich S. L., Avilion A. A., Chiu C.-P., et al. (1995) The RNA component of human telomerase. Science 269, 1236-1241.
13. Fu W., Begley J. G., Killen M. W., and Mattson M. P. (1999) Anti-apoptotic role of telomerase in pheochromocytoma cells. J. Biol. Chem. 274, 7264-7271.
14. Furukawa K., Fu W., Witke W., Kwiatkowski D. J., and Mattson M. P. (1997) The actin-severing protein gelsolin modulates calcium channel and NMDA receptor activities and vulnerability to excitotoxicity in hippocampal neurons. J. Neurosci. 17, 8178-8186.
15. Giuffrida A. M., Hamberger A., and Serra I. (1976) Biosynthesis of DNA and RNA in neuronal and glial cells from various regions of developing rat brain. J. Neurosci. Res. 2, 203-215.
16. Greenberg R. A., Allsopp R. C., Chin L., Morin R.B., and DePinho R. A. (1998) Expression of mouse telomerase reverse transcriptase during development, differentiation and proliferation. Oncogene 16, 1723-1730.
17. Greider C. W. and Blackburn E. H. (1996) Telomeres, telomerase and cancer. Sci. Amer. Feb., 92-97.
18. Guo Q., Fu W., Xie J., Luo H., Sells S. F., Geddes J. W., et al. (1998) Par-4 is a novel mediator of neuronal degeneration associated with the pathogenesis of Alzheimer's disease. Nature Med. 4, 957-962.
19. Guo Q., Fu W., Sopher B. L., Miller M. W., Ware C. B., Martin G. M., and Mattson M. P. (1999) Increased vulnerability of hippocampal neurons to excitotoxic necrosis in presenilin-1 mutant knockin mice. Nature Med. 5, 101-106.
20. Jenner P. and Olanow C. W. (1998) Understanding cell death in Parkinson's disease. Ann. Neurol. 44, S72-S84.
21. Karlseder J., Broccoli D., Dal Y., Hardy S., and de Lange T. (1999) p53-and ATM-dependent apoptosis induced by telomeres lacking TRF2. Science 283, 1321-1325.
22. Kim N. W., Piatyszek M. A., Prowse K. R., Harley C. B., West M. D., Ho P. L. C., et al. (1994) Specific association of human telomerase activity with immortal cells and cancer. Science 266, 2011-2015.
23. Kondo S., Tanaka Y., Kondo Y., Hitomi M., Barnett G. H., Ishizaka Y., et al. (1998) Antisense telomerase treatment: induction of two distinct pathways, apoptosis and differentiation. FASEB J. 12, 801-811.
24. Kruk P. A., Balajee A. S., Rao K. S., and Bohr V. A. (1996) Telomere reduction and telomerase inactivation during neuronal cell differentiation. Biochem. Biophys. Res. Commun. 224, 487-492.
25. Li H., Cao Y., Berndt M. C., Funder J. W., and Liu J. P. (1999) Molecular interactions between telomerase and the tumor suppressor protein p53 in vitro. Oncogene 18, 6785-6794.
26. Lingner J., Hughes T. R., Shevchenko A., Mann M., Lundblad V., and Cech T. R. (1997) Reverse transcriptase motifs in the catalytic subunit of telomerase. Science
27. Mattson M. P., Dou P., and Kater S. B. (1988) Outgrowth-regulating actions of glutamate in isolated hippocampal pyramidal neurons. J. Neurosci. 8, 2087-2100.
28. Mattson M. P. (1997) Cellular actions of ß-amyloid precursor protein, and its soluble and fibrillogenic peptide derivatives. Physiol. Rev. 77, 1081-1132.
29. Mattson M. P., Keller J. N., and Begley J. G. (1998) Evidence for synaptic apoptosis. Exp. Neurol. 153, 35-48.
30. Mattson M. P., Culmsee C., and Yu Z. F. (2000) Apoptotic and anti-apoptotic mechansims in stroke. Cell Tiss. Res. (In Press.)
31. Oppenheim R. W. (1989) The neurotrophic theory and naturally occurring motoneuron death. Trends Neurosci. 12, 252-255.
32. Pandita T. K., Hall E. J., Hei T. K., Piatyszek M. A., Wright W. E., Piao C. Q., et al. (1996) Chromosome end-to-end associations and telomerase activity during cancer progression in human cells after treatment with alpha-particles simulating radon progeny. Oncogene 13, 1423-1430.
33. Pandita T. K., Benvenuto J. A., Shay J. W., Pandita R. K., Rakovitch E., Geard C. R., et al. (1997) Effect of penclomedine (NSC-338720) on telomere fusions, chromatin blebbing, and cell viability with and without telomerase activity and abrogated p53 function. Biochem. Pharmacol. 53, 409-415.
34. Portera-Cailiau C., Hedreen J. C., Price D. L., and Koliatsos V. (1995) Evidence for apoptotic cell death in Huntington's disease and excitotoxic animal models. J. Neurosci. 15, 3775-3787.
35. Rubin L. L. (1998) Neuronal cell death: an updated view. Prog. Brain Res. 117, 3-8.
36. Sharma H. W., Sokoloski J. A., Perez J. R., Maltese J. Y., Sartorelli A. C., Stein C. A., et al. (1995) Differentiation of immortal cells inhibits telomerase activity. Proc. Natl. Acad. Sci. USA 92, 12,343-12,346.
37. Tahara H., Yasui W., Tahara E., Fujimoto J., Ito K., Tamai K., et al. (1999) Immuno-histochemical detection of human telomerase catalytic component, hTERT, in human colorectal tumor and non-tumor tissue sections. Oncogene 18, 1561-1567.
38. Ulaner G. A. and Giudice L. C. (1997) Developmental regulation of telomerase activity in human fetal tissues during gestation. Mol. Hum. Reprod. 3, 769-773.
39. Vaziri H. and Benchimol S. (1998) Reconstitution of telomerase activity in normal cells leads to elongalion of telomeres and extended replicative lifespan. Curr. Biol. 8, 279-282.
40. Vaziri H., Squire J. A., Pandita T. K., Bradle G., Kuba R. M., Zhang H., et al. (1999) Analysis of genomic integrity and p53-dependent G1 checkpoint in telomerase-induced extended-lifespan human fibroblasts. Mol. Cell. Biol. 19, 2373-2379.
41. Wright W. E., Piatyszek M. A., Rainey W. E., Byrd W., and Shay J. W. (1996) Telomerase activity in human germline and embryonic tissues and cells. Dev. Genet. 18, 173-179.
42. Zhang X., Mar V., Zhou W., Harrington L., and Robinson M. O. (1999) Telomere shortening and apoptosis in telomerase-inhibited human tumor cells. Genes Dev. 13, 2388-2399.
43. Zhu J., Wang H., Bishop J. M. and Blackburn E. H. (1999) Telomerase extends the lifespan of virsu-transformed human cells without net telomere lengthening. Proc. Natl. Acad. Sci. USA 96, 3723-3728.